Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Current Taxes (2016 - 2025)

Trinity Biotech's Current Taxes history spans 17 years, with the latest figure at $348000.0 for Q4 2025.

  • On a quarterly basis, Current Taxes fell 4.4% to $348000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $348000.0, a 4.4% decrease, with the full-year FY2025 number at $348000.0, down 4.4% from a year prior.
  • Current Taxes hit $348000.0 in Q4 2025 for Trinity Biotech, down from $472000.0 in the prior quarter.
  • Over the last five years, Current Taxes for TRIB hit a ceiling of $1.0 million in Q3 2021 and a floor of $2000.0 in Q4 2023.
  • Historically, Current Taxes has averaged $277833.3 across 5 years, with a median of $285000.0 in 2023.
  • Biggest five-year swings in Current Taxes: crashed 97.94% in 2022 and later soared 18100.0% in 2024.
  • Tracing TRIB's Current Taxes over 5 years: stood at $22000.0 in 2021, then increased by 27.27% to $28000.0 in 2022, then tumbled by 92.86% to $2000.0 in 2023, then soared by 18100.0% to $364000.0 in 2024, then fell by 4.4% to $348000.0 in 2025.
  • Business Quant data shows Current Taxes for TRIB at $348000.0 in Q4 2025, $472000.0 in Q2 2025, and $364000.0 in Q4 2024.